Table 1

Summary of data collection and timeline

Data collectionTimeline (months from baseline)
Physical examination (blood pressure, height, weight)X
Laboratory serum examination: eGFR, uric acid level, TC, LDL, HDL, glucoseX
Patient demographicsX
Gout attacks: frequency, characteristics, medication use and adherence (GAQ)XXXXXXXXX
Presence and burden of tophi (TIQ-20)XXXX
Comorbidity (SCQ)XXX
Physical and mental health (SF-36) and physical activity (IPAQ)XXX
Quality of life (EQ-5D)XXX
Medication use (general) (BMQ)XXX
Diet (FFQ) and smoking statusXXX
  • BMQ, Brief Medication Questionnaire; eGFR, estimated glomerular filtration rate; EQ-5D, EuroQol 5 Dimensions; FFQ, Food Frequency Questionnaire; GAQ, Gout Assessment Questionnaire; HDL, high-density¬†lipoprotein cholesterol; IPAQ,¬†International Physical Activity Questionnaire; LDL, low-density lipoprotein cholesterol; SCQ, Self-administered Comorbidity Questionnaire; SF-36, Short Form health survey; TC, total cholesterol; TIQ-20, Tophus Impact Questionnaire 20.